The Safety and Efficacy of Gefapixant (AF-219/MK-7264) in Female Participants With Interstitial Cystitis /Bladder Pain Syndrome (MK-7264-005)
Clinical trial NCT01569438 · TERMINATED
Trial details
- NCT number
- NCT01569438
- Sponsor
- Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-13
- Primary completion
- 2014-05-01
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.